By Jamie Deckoff-Jones, MD
At the present time, there are over 100 bills in play around the country which seek to mandate or eliminate exemptions for vaccines. In NY state, there is a bill to mandate HPV vaccine for all students entering the 6th grade. HPV vaccination is already mandated in Virginia and the District of Columbia.
Our children are sicker than they have ever been, plagued by immune dysfunction and neurodevelopmental disorders. Meanwhile, in the name of stamping out infectious diseases, which has succeeded exactly once in over 80 years of trying, the CDC is recommending that all children be protected against viruses that might cause a very few of them to get cancer in 30 or 40 years. In the process, they must get 3 injections containing a big slug of an aluminum adjuvant, plus foreign DNA.
Every vaccine that is mandated is a huge windfall for the manufacturer, who bears no liability in the U.S. In the case of the HPV vaccine, the retail price is about $500 for the three shots. Merck has reported sales of over a billion dollars a year since 2007 from the push to vaccinate teens.
There are two vaccines for HPV in use. Gardasil, approved in 2006, prevents 4 subtypes of HPV (6,11,16 and 18). Cervarix prevents 2 strains (16 and 18) and has been widely used in Europe. Persistent infection with HPV 16 and 18 is seen in 70% of cervical cancers in white women. Subtypes 6 and 11 cause genital warts. HPV related cancers in black women most frequently involve different subtypes, something that has been completely ignored when recommending this vaccine for all teenagers.
From Medscape Oct 2013: Vaccines Do Not Cover Most Common HPV Types in Black Women For whites with CIN1, the most frequent HPV subtypes were 16, 18, 56, 39, and 66. But for blacks with CIN1, the most frequent HPV subtypes were 33, 35, 58, and 68… In CIN2/3, HPV 16, 18, 33, 39, and 59 were the most common genotypes detected in white women, whereas HPV 31, 35, 45, 56, 58, 66, and 68 were the most prevalent in African American women.
Gardasil 9 was approved recently. It prevents 9 strains of HPV (6, 11, 16, 18, 31, 33, 45, 52, and 58). It is advertised as prevention for 90% of cervical cancers, no mention of racial disparity. There is no post marketing data on it yet. It contains 500 mcg of the aluminum adjuvant per dose compared to 225 mcg in Gardasil. It also contains polysorbate 80. Concerns have been raised about the impact of polysorbate 80 on the gut microbiome and animal studies have suggested that it might promote colitis, metabolic syndrome and infertility.
Here are numbers directly from the Gardasil 9 package insert.
Out of the 13,236 individuals who were administered GARDASIL 9 and had safety follow-up, 305 reported a serious adverse event; representing 2.3% of the population. As a comparison, of the 7,378 individuals who were administered GARDASIL and had safety follow-up, 185 reported a serious adverse event; representing 2.5% of the population.
In all of the clinical trials with GARDASIL 9 subjects were evaluated for new medical conditions potentially indicative of a systemic autoimmune disorder. In total, 2.4% (321/13,234) of GARDASIL 9 recipients and 3.3% (240/7,378) of GARDASIL recipients reported new medical conditions potentially indicative of systemic autoimmune disorders, which were similar to rates reported following GARDASIL, AAHS control, or saline placebo in historical clinical trials.
These numbers are pretty shocking, especially when you consider the source is well known for scientific fraud and data manipulation in the pursuit of profit.
Read the full article here at Dr. Deckoff-Jones, MD’s X Rx Blog.